Insider Trading Activity - CRANDELL KEITH

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for CRANDELL KEITH

Goto 0, 1, 2, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-04-02 Purchase	2024-04-04 4:30 pm	Boundless Bio Inc.	BOLD	CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner	200,000	$16	$3,200,000	1,181,766 (Indirect)	View
2024-02-15 Purchase	2024-02-20 5:37 pm	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	3,200,000	$6.25	$20,000,000	15,456,594 (Indirect)	View
2024-02-08 Purchase	2024-02-12 5:43 pm	Sana Biotechnology Inc.	SANA	CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner	1,818,181	$5.5	$9,999,996	22,747,272 (Indirect)	View
2023-11-13 Purchase	2023-11-15 6:54 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	35,010	$11.77	$412,140	4,131,207 (Indirect)	View
2023-11-08 Purchase	2023-11-13 7:00 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	140,605	$10.98	$1,543,563	4,096,197 (Indirect)	View
2023-11-03 Purchase	2023-11-07 6:59 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	95,694	$11.49	$1,099,945	3,955,592 (Indirect)	View
2023-09-28 Purchase	2023-09-29 6:53 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	76,511	$13.68	$1,046,848	3,859,898 (Indirect)	View
2023-09-26 Purchase	2023-09-27 8:18 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	58,504	$11.97	$700,464	3,783,387 (Indirect)	View
2023-09-22 Purchase	2023-09-25 9:38 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	100,740	$11.19	$1,127,064	3,724,883 (Indirect)	View
2023-09-19 Purchase	2023-09-20 06:16 am	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,500,000	$17	$25,500,000	3,624,143 (Indirect)	View
2022-10-24 Purchase	2022-10-26 8:01 pm	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	800,000	$17	$13,600,000	6,128,297 (Indirect)	View
2022-09-13 Purchase	2022-09-15 6:53 pm	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	5,000,000	$1.5	$7,500,000	13,854,098 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-06-12 Exercise	2024-06-14 4:21 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	7,777	$0	5,766,332 (Direct)	View
2024-06-13 Option Award	2024-06-14 4:21 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	27,360	$0	5,766,332 (Direct)	View
2024-06-10 Conversion	2024-06-10 7:46 pm	N/A N/A	Rapport Therapeutics Inc.	RAPP	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner	35,652,876	$0	3,728,738 (Indirect)	View
Ownership	2024-06-06 7:14 pm	N/A N/A	Rapport Therapeutics Inc.	RAPP	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner	0	$0	3,728,738 (Indirect)	View
2024-04-02 Conversion	2024-04-04 4:30 pm	N/A N/A	Boundless Bio Inc.	BOLD	CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner	4,851,442	$0	1,181,766 (Indirect)	View
Ownership	2024-03-27 7:56 pm	N/A N/A	Boundless Bio Inc.	BOLD	CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner	0	$0	2,494,095 (Indirect)	View
2024-02-06 Option Award	2024-02-09 4:10 pm	N/A N/A	Twist Bioscience Corp	TWST	CRANDELL KEITH Director	5,815	$0	18,004 (Direct)	View
2023-12-08 Other	2023-12-12 7:53 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,879,654	$0	32,424,564 (Indirect)	View
2023-09-19 Conversion	2023-09-20 06:16 am	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	17,424,704	$0	3,624,143 (Indirect)	View
Ownership	2023-09-14 9:29 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	0	$0	28,045,420 (Indirect)	View
2023-07-28 Other	2023-08-10 8:28 pm	N/A N/A	DA32 Life Science Tech Acquisition Corp.	DALS	CRANDELL KEITH Director 10% Owner	1,600,000	$0	2,250,000 (Indirect)	View
2023-06-14 Exercise	2023-06-16 5:52 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	4,771	$0	5,751,048 (Direct)	View
2023-06-15 Option Award	2023-06-16 5:52 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	19,853	$0	5,751,048 (Direct)	View
2023-04-03 Option Award	2023-04-04 6:23 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	1,170	$11.16	131,236 (Direct)	View
2023-02-07 Option Award	2023-02-09 6:08 pm	N/A N/A	Twist Bioscience Corp	TWST	CRANDELL KEITH Director 10% Owner	8,212	$0	12,189 (Direct)	View
2023-01-03 Option Award	2023-01-04 4:03 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	1,015	$12.86	142,190 (Direct)	View
2023-01-03 Option Award	2023-01-04 4:03 pm	2023-12-31 2033-01-03	Quanterix Corp	QTRX	CRANDELL KEITH Director	20,207	$0	142,190 (Direct)	View
2022-10-24 Conversion	2022-10-26 8:01 pm	N/A N/A	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	41,344,576	$0	6,128,297 (Indirect)	View
Ownership	2022-10-19 8:08 pm	N/A N/A	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	0	$0	11,456,594 (Indirect)	View
2022-10-03 Option Award	2022-10-05 4:04 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	1,326	$10.48	120,968 (Direct)	View
2022-09-02 Other	2022-09-07 8:29 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,018	$0	1,126,748 (Indirect)	View
2022-08-30 Other	2022-09-01 5:20 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,006	$0	1,117,864 (Indirect)	View
2022-08-24 Other	2022-08-26 5:12 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,006	$0	1,109,010 (Indirect)	View
2022-08-18 Other	2022-08-22 5:14 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,503	$0	582,653 (Indirect)	View
2022-08-12 Other	2022-08-16 9:04 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,552,509	$0	1,613,232 (Indirect)	View
2022-07-01 Option Award	2022-07-06 4:07 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	893	$16.79	119,642 (Direct)	View
2022-06-15 Exercise	2022-06-17 4:15 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	1,379	$0	5,739,165 (Direct)	View
2022-06-16 Option Award	2022-06-17 4:15 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	12,741	$0	5,739,165 (Direct)	View
2022-06-08 Other	2022-06-10 9:27 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,503	$0	564,945 (Indirect)	View
2022-06-02 Other	2022-06-06 8:24 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,502	$0	10,955,581 (Indirect)	View
2022-04-01 Option Award	2022-04-05 4:42 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	492	$30.47	118,749 (Direct)	View
2022-02-08 Option Award	2022-02-10 7:32 pm	N/A N/A	Twist Bioscience Corp	TWST	CRANDELL KEITH Director	3,491	$0	80,024 (Direct)	View
2021-11-16 Other	2022-01-05 4:06 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	619,520	$0	741,779 (Indirect)	View
2022-01-03 Option Award	2022-01-05 4:06 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	307	$42.41	741,779 (Direct)	View
2022-01-03 Option Award	2022-01-05 4:06 pm	2022-12-31 2032-01-03	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	6,670	$0	741,779 (Direct)	View
2021-12-20 Other	2021-12-22 5:59 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,811,207	$0	12,527,079 (Indirect)	View
2021-11-29 Other	2021-12-01 6:30 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,485	$0	12,205,620 (Indirect)	View

Goto 0, 1, 2, Next

Insider Trading & Ownership - CRANDELL KEITH